PDF 1.516kB - TOBIAS-lib - Universität Tübingen

Literaturverzeichnis
Mariya Gosheva
atherothrombotic events in patients with acute myocardial infarction. Circulation.
2004, 109: 3171-3175.
56. Serebruany, VL, Steinhubl, SR, Berger, PB, Malinin, AI, Bhatt, DL and
Topol, EJ. Variability in platelet responsiveness to clopidogrel among 544
individuals. J Am Coll Cardiol. 2005, 45: 246-251.
57. Angiolillo, DJ, Fernandez-Ortiz, A, Bernardo, E, Ramirez, C, Sabate, M,
Banuelos, C, Hernandez-Antolin, R, Escaned, J, Moreno, R, Alfonso, F and
Macaya, C. High clopidogrel loading dose during coronary stenting: effects on
drug response and interindividual variability. Eur Heart J. 2004, 25: 1903-1910.
58. Geisler, T, Langer, H, Wydymus, M, Göhring, K, Zürn, C, Bigalke, B,
Stellos, K, May, AE and Gawaz, M. Low response to clopidogrel is associated
with cardiovascular outcome after coronary stent implantation. Eur Heart J.
2006, 27: 2420-2425.
59. Grossmann, R, Sokolova, O, Schnurr, A, Bonz, A, Porsche, C,
Obergfell, A, Lengenfelder, B, Walter, U and Eigenthaler, M. Variable extent
of clopidogrel responsiveness in patients after coronary stenting. Thromb
Haemost. 2004, 92: 1201-1206.
60. Nguyen, TA, Diodati, JG and Pharand, C. Resistance to clopidogrel: a
review of evidence. J Am Coll Cardiol. 2005, 45: 1157-1164.
61. Geisler, T and Gawaz, M. Resistenzen gegenüber
Plättchenfunktionshemmern: ein reales klinisches Problem. Herz. 2008, 33:
260-268.
62. Taubert, D, Kastrati, A, Harlfinger, S, Gorchakova, O, Lazar, A, von
Beckerath, N, Schmög, A and Schmög, E. Pharmacokinetics of clopidogrel
after administration of a high loading dose. Thromb Haemost. 2004, 92: 311-
316.
63. Kastrati, A, Schmög, A and Schmög, E. Are we making efficient use of
clopidogrel? Eur Heart J. 2004, 25: 454-456.
64. Lau, WC, Gurbel, PA, Watkins, PB, Neer, CJ, Hopp, AS, Carville, DGM,
Guyer, KE, Tait, AR and Bates, ER. Contribution of hepatic cytochrome P450
3A4 metabolic activity to the phenomen of clopidogrel resistance. Circulation.
2004, 109: 166-171.
65. Suh, JW, Koo, BK, Zhang, SY, Park, KW, Cho, JY, Jang, IJ, Lee, DS,
Sohn, DW, Lee, MM and Kim, HS. Increased risk of atherothrombotic events
associated with cytochrome P450 3A5 polymorphism in patients taking
clopidogrel. CMAJ. 2006, 174: 1715-1722.
66. Hulot, JS, Bura, A, Villard, E, Azizi, M, Remones, V, Goyenvalle, C,
Aiach,M, Lechat, P and Gaussem, P. Cytochrome P450 2C19 loss-of-function
- 63 -